1-112918054-C-CAATA
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_003051.4(SLC16A1):c.362-14_362-11dupTATT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0064 ( 5 hom., cov: 0)
Exomes 𝑓: 0.0026 ( 2 hom. )
Consequence
SLC16A1
NM_003051.4 intron
NM_003051.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.497
Genes affected
SLC16A1 (HGNC:10922): (solute carrier family 16 member 1) The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP6
Variant 1-112918054-C-CAATA is Benign according to our data. Variant chr1-112918054-C-CAATA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1336772.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=2}.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00643 (930/144614) while in subpopulation AFR AF = 0.0102 (395/38742). AF 95% confidence interval is 0.00937. There are 5 homozygotes in GnomAd4. There are 476 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 5 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A1 | NM_003051.4 | c.362-14_362-11dupTATT | intron_variant | Intron 3 of 4 | ENST00000369626.8 | NP_003042.3 | ||
SLC16A1 | NM_001166496.2 | c.362-14_362-11dupTATT | intron_variant | Intron 3 of 4 | NP_001159968.1 | |||
SLC16A1 | XM_047428789.1 | c.362-14_362-11dupTATT | intron_variant | Intron 3 of 4 | XP_047284745.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00644 AC: 931AN: 144542Hom.: 5 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
931
AN:
144542
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000856 AC: 52AN: 60732 AF XY: 0.000813 show subpopulations
GnomAD2 exomes
AF:
AC:
52
AN:
60732
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00256 AC: 1830AN: 714864Hom.: 2 Cov.: 0 AF XY: 0.00250 AC XY: 904AN XY: 361898 show subpopulations
GnomAD4 exome
AF:
AC:
1830
AN:
714864
Hom.:
Cov.:
0
AF XY:
AC XY:
904
AN XY:
361898
Gnomad4 AFR exome
AF:
AC:
114
AN:
14632
Gnomad4 AMR exome
AF:
AC:
26
AN:
12938
Gnomad4 ASJ exome
AF:
AC:
13
AN:
14298
Gnomad4 EAS exome
AF:
AC:
35
AN:
24286
Gnomad4 SAS exome
AF:
AC:
34
AN:
22962
Gnomad4 FIN exome
AF:
AC:
111
AN:
20920
Gnomad4 NFE exome
AF:
AC:
1411
AN:
571870
Gnomad4 Remaining exome
AF:
AC:
84
AN:
30744
Heterozygous variant carriers
0
75
149
224
298
373
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00643 AC: 930AN: 144614Hom.: 5 Cov.: 0 AF XY: 0.00678 AC XY: 476AN XY: 70210 show subpopulations
GnomAD4 genome
AF:
AC:
930
AN:
144614
Hom.:
Cov.:
0
AF XY:
AC XY:
476
AN XY:
70210
Gnomad4 AFR
AF:
AC:
0.0101957
AN:
0.0101957
Gnomad4 AMR
AF:
AC:
0.00522912
AN:
0.00522912
Gnomad4 ASJ
AF:
AC:
0.000581734
AN:
0.000581734
Gnomad4 EAS
AF:
AC:
0.00421348
AN:
0.00421348
Gnomad4 SAS
AF:
AC:
0.00132802
AN:
0.00132802
Gnomad4 FIN
AF:
AC:
0.0173982
AN:
0.0173982
Gnomad4 NFE
AF:
AC:
0.00392978
AN:
0.00392978
Gnomad4 OTH
AF:
AC:
0.007
AN:
0.007
Heterozygous variant carriers
0
40
80
121
161
201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
SLC16A1: BS2 -
not specified Uncertain:1
Nov 11, 2019
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at